Muscular Dystrophy Clinical Trials

A listing of Muscular Dystrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17672 clinical trials
Featured trial
Alzheimer's Clinical Research Study

Have you or a loved one been diagnosed with Alzheimer's Disease? You may be interested in a research study at Be Well MD in conjunction with Advanced Clinical Research.

dementia
moderate dementia
  • 33 views
  • 08 Dec, 2020
  • 1 location
Featured trial
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

The goal of this research study is to understand whether aging affects vaginal health differently in menopausal women living with and without HIV and whether vaginal estradiol improves symptoms of vaginal atrophy in menopausal women living with HIV. 

  • 79 views
  • 03 Mar, 2021
  • 1 location
Featured trial
ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Adult Subjects with Recurrent Clostridioides difficile Infection (RCDI)

ECOSPOR IV is a Phase 3, multicenter, Open Label study to evaluate the safety and tolerability of SER-109 in adult subjects with recurrent CDI.

clostridium difficile
  • 77 views
  • 21 Dec, 2020
  • 77 locations
Featured trial
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390 + INCMGA00012.  

  • 2 views
  • 10 May, 2022
  • 2 locations
Featured trial
A Phase 2, Single-Arm, Open-Label Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy by Immune Effector Cell Therapy

The purpose of this study is to assess the safety and efficacy of oral administration of itacitinib once daily for the prevention of cytokine release syndrome (CRS) in male or female participants aged 12 years or older and who are planning to receive tisagenlecleucel or axicabtagene ciloleucel immune effector cell …

hematologic cancer
cancer
  • 126 views
  • 10 May, 2022
  • 10 locations
Featured trial
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

  • 831 views
  • 23 Nov, 2020
  • 5 locations
Featured trial
C3711005

The study will evaluate the effect of coadministration of a range of doses of DGAT2i with 1 dose of ACCi, on hepatic steatosis and the ability of DGAT2i to mitigate ACCi-induced elevations in serum triglycerides. The study has a 2-part design with sequential conduct of Part 1 and Part 2 …

  • 814 views
  • 10 Jan, 2022
  • 3 locations
Featured trial
C2541013 MIRNA NASH  

The study aims to evaluate two, orally administered, investigational agents - PF-06865571 (DGAT2 inhibitor) and the coadministration of PF-06865571 with PF-05221304 (ACC inhibitor). This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement …

  • 1375 views
  • 01 Oct, 2022
  • 44 locations
Featured trial
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

  • 555 views
  • 25 Mar, 2021
  • 1 location
Featured trial
High blood pressure? You may qualify for a clinical research study.

High blood pressure? You may qualify for a clinical research study.

  • 434 views
  • 08 Nov, 2020
  • 1 location